Poultry Medicine/Pharmaceuticals Market to Hit USD 6.68 Billion by 2029 with 5.9% CAGR | MarketsandMarkets
The poultry medicine/pharmaceuticals market valued at US$ 4.73 billion in 2023, is forecasted to grow at a robust CAGR of 5.9%, reaching US$ ...
cweb2d
Biogen Shares Rise on FDA Approval for Alzheimer’s Drug, But CWEB Analyst Insight Highlights Market Impact
Biogen Inc. (BIIB) saw its stock climb 1.7% on Monday afternoon, reaching a nearly two-week high following positive ...
Hosted on MSN2d
Mounjaro menu plan: What foods to eat and avoid for optimal results
What foods to eat and avoid for optimal results. Whether you've been prescribed Mounjaro (tirzepatide) for type 2 diabetes, ...
Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk
Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...
Novo Nordisk Stock Soars on New Weight-Loss Drug Results
Novo Nordisk scored a much-needed win on Friday, with early-stage data on a new weight-loss drug that suggested it could work better than the obesity blockbusters already on the market. Novo American ...
Confidence Is Just As Dangerous When It's Too Low As When It's Too High
To attain goals, you need confidence. It takes self-assurance to pursue what matters most to you. But too much confidence has ...
The FDA is about to make weight-loss drugs a lot harder to get
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Psoriasis Drugs Market To Reach USD 52.34 Billion By 2033, Growing At A 11.50% CAGR
psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...
The Motley Fool11d
Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?
Eli Lilly's stock price finished Jan. 16 down 21% from a peak it set last September. The sales trajectory of Mounjaro and Zepbound tapered off in the second half of 2024. An oral weight-loss candidate ...